Fournier's Gangrene clinical trials at UC Health
1 in progress, 0 open to eligible people
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Sorry, in progress, not accepting new patients
The purpose of this study is to determine whether AB103 is safe and effective in the treatment of patients with necrotizing soft tissue infections receiving standard of care therapy.
at UC Davis UCLA UCSD